February 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device.

February 28, 2022  – The normal functioning of human body requires a steady flow of energy. This energy in the form of adenosine triphosphate (ATP) is produced by breaking down carbon sources like glucose, lipids, or amino acids. The tricarboxylic acid (TCA) cycle, one of the most important ATP-producing processes in the mitochondria, is a major hub of metabolites and is known for ensuring a fine balance between its cyclic intermediates, referred to as the 'metabolic flux.'

February 28, 2022 – Research from the University of Cincinnati is examining a protein that plays a key role in heart failure.  

February 28, 2022 — A new collection of scientific articles published today shines a light on the differences between men and women when it comes to heart health.

February 28, 2022 – Despite improvements in treatment and increased public awareness about prevention, cardiovascular disease (CVD) is still the leading cause of death worldwide. CVD causes half of all deaths in several developed countries and is the major cause of adult death in many developing countries. And though some cardiovascular events aren't fatal, strokes and other forms of heart disease may still be debilitating enough to seriously affect functional ability.

February 25, 2022 – University of Alabama at Birmingham researchers are calling for a wider study of racial differences in high blood pressure after finding two clinical measures that are significantly greater in Blacks with resistant hypertension, as compared to whites with resistant hypertension.

February 25, 2022 – Teleflex Incorporated, a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI).

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today, along with OrbusNeich, announced FDA PMA approval of OrbusNeich’s Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter.

Physician-scientists in the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence (AI) tool that can effectively identify and distinguish between two life-threatening heart conditions that are often easy to miss: hypertrophic cardiomyopathy and cardiac amyloidosis. The new findings were published in JAMA Cardiology. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now